Director, Commercial Operations at Gilead Sciences

Uxbridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Proven experience managing complex, multi-country environments in highly diverse regions like CAMENA (Central Asia, Middle East, and North Africa)
Deeply experienced professional capable of navigating political, economic, and cultural diversity
Strategic thinker with expertise in health infrastructure development and innovative access solutions
Ability to influence and strengthen relationships with governments, payers, NGOs, and evolving health systems
Experience in distributor onboarding, development, and management, particularly in regulatory, supply chain, and market access complexities
Proficiency in managing P&L, budgets, and resource allocation
Skills in building and nurturing high-impact partnerships with local governments, international organizations, and key stakeholders

Responsibilities

Lead the CAMENA region with strategic focus on North Africa, prioritizing successful distributor partnership under Project ATLAS
Drive onboarding, development, and management of a high-performing distributor in North Africa capable of handling regulatory, supply chain, and market access complexities
Develop and execute a comprehensive regional plan leveraging disease burden, economic drivers, and access gaps, emphasizing key markets like Iran, Iraq, Lebanon, Kazakhstan, and North Africa
Provide strategic and operational leadership to position Gilead as a trusted partner, influencing relationships with governments, payers, NGOs, and health systems
Build and nurture strong partnerships with local governments, international organizations, and key stakeholders, especially in North Africa
Direct onboarding and development of a new distributor in North Africa, including training, capacity building, and operational integration aligned with Gilead’s objectives
Manage P&L, budgets, and resource allocation for the CAMENA region, focusing on North Africa initiatives and regional targets
Deepen relationships with existing distributor and licensee partners, optimizing contractual and operational performance for accelerated access in complex markets
Create tailored market access and business development strategies for HIV, HCV, HBV, and pipeline products in access-challenged markets, enabling regional launches with local partnerships
Lead cross-functional collaboration

Skills

Strategic Planning

Commercial Operations

Patient Access

Distributor Management

Multi-Country Management

Health Infrastructure Development

Regional Leadership

Pharmaceutical Commercialization

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free